Catalent Pharma

@CatalentPharma

From drug and biologic development services to delivery technologies to supply solutions. Catalent. More products. Better treatments. Reliably supplied.™

Somerset, NJ
Vrijeme pridruživanja: ožujak 2010.

Tweetovi

Blokirali ste korisnika/cu @CatalentPharma

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @CatalentPharma

  1. prije 8 sati

    In this poster Catalent experts share an example of how a high-throughput preformulation approach was implemented in order to enable a shorter time and less labor-intensive screening for a broad range of conditions. Download here:

    Poništi
  2. Poništi
  3. Join Catalent and Natural Products Expo West March 3-7 in Aneheim California. Visit us at booth 4183 and schedule a meeting with our experts.

    Poništi
  4. proslijedio/la je Tweet
    3. velj

    Did you know? The CRS Corporate Membership Founding Members are meeting at CRS HQ in New Jersey this month. As newly appointed members of the Industry Foresight Council, they will submit an agenda to the CRS Board of Directors & meet for lunch and in-depth discussions.

    Poništi
  5. 4. velj

    Hear from experts as they share insights into the key processes in formulation, analytical and mfg activities for , and products and discuss key considerations for transitioning and biologics into the clinic.

    Poništi
  6. proslijedio/la je Tweet
    4. velj

    With the acquisition of , spreads its into the cell and gene market. Detailed insight on this emerging trend in cell and gene therapy market is available on

    Poništi
  7. 4. velj

    Hosted in partnership with , this workshop will show how a comprehensive end-to-end solution has the potential to provide higher quality and improved yield of with reduced cost and time. Attend this free event:

    Poništi
  8. 3. velj
    Poništi
  9. 3. velj

    Catalent Chairman and CEO John Chiminski triggers a $315M-plus wager on the booming cell therapy market now in the making. Read the full interview:

    Poništi
  10. 3. velj

    Catalent To Acquire Leading Cell Therapy Company MaSTherCell Global for $315 Million, Creating an Industry-Leading Cell & Gene Therapy Platform Read more:

    Poništi
  11. 2. velj

    Join Catalent and Industries on March 12 for an interactive workshop on hot melt extrusion. Register today for this complimentary event held at Catalent’s , NJ headquarters.

    Poništi
  12. 30. sij

    Discover strategies for selecting suitable formulation techniques for poorly soluble drugs, and learn about recent advances in screening and modelling for predicting solubility. Download today.

    Poništi
  13. 30. sij

    Download this on demand and hear Catalent's Greg Bleck discuss GPEx® Boost cell line development technology and how it can improve through higher titers and specific productivities, Download today:

    Poništi
  14. 29. sij

    There is a growing need for streamlining import and export strategies and support in the APAC region. Register for this to get expert insights on using Singapore as a clinical supply hub.

    Poništi
  15. 29. sij

    Join Catalent and Industries on March 12 for an interactive workshop on hot melt extrusion. Register today for this complimentary event held at Catalent’s , NJ headquarters.

    Poništi
  16. 29. sij

    Catalent is pleased to announce the appointment of Ricci Whitlow as President, Clinical Supply Services. Read the press release:

    Poništi
  17. 29. sij

    Polysorbate-80 (PS-80) is a surfactant commonly used as an excipient to improve API stability. This case study describes how to quantitate and characterize . Learn more and download here:

    Poništi
  18. 28. sij

    Join Catalent at in Washington, D.C. and hear Chris Hepler discuss Conversion of a potency assay from cell-based binding to . Visit us at stand 18, January 28-30. Schedule a meeting with our experts today.

    Poništi
  19. 28. sij

    Final hours to Register for this to hear experts walk through solutions that address the challenges in pediatric drug development that have the potential to improve patient outcomes. Register Today.

    Poništi
  20. 27. sij

    Learn how Catalent tests therapeutic antibodies to ensure stability, safety and efficacy in this scientific poster that explores Multidimensioal evaluation of mAb degradation. Download it today!

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·